Surrozen, Inc. ('Surrozen” or the 'Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with ...
Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsRyan Schaffer - CFO & DirectorNiki WallrothDavid Barrett ...
Gyre Therapeutics ("Gyre") (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...
TipRanks on MSN
Expensify Reports Q3 2025 Financial Results and AI Upgrade
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals ...
Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its operating and financial results ...
Please note that the limited information that follows in this press release is not adequate to make an informed investment ...
MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights ...
An expense account sounds simple enough, but it actually means two different things in business. First, it’s the process that lets employees pay for work expenses and get reimbursed by their company.
New housing under construction in New Hampshire, March 2023. Housing was found to be the main expense squeezing families. The median household income in New Hampshire falls nearly $2000 short of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback